[{"id":"fbacc4d8-d3e5-4dce-8239-27f456349d57","acronym":"GEINOCANN","url":"https://clinicaltrials.gov/study/NCT03529448","created_at":"2022-02-12T17:21:26.896Z","updated_at":"2024-07-02T16:35:35.596Z","phase":"Phase 1/2","brief_title":"TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma","source_id_and_acronym":"NCT03529448 - GEINOCANN","lead_sponsor":"Grupo Español de Investigación en Neurooncología","biomarkers":" MDK","pipe":"","alterations":" ","tags":["MDK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e temozolomide • delta-9-tetrahydrocannabinol/cannabidiol (TN-TC11G)"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 08/18/2023","start_date":" 08/18/2023","primary_txt":" Primary completion: 03/01/2025","primary_completion_date":" 03/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-09-27"}]